We have defined a DM1-circRNA signature and identified circARHGAP10 as a promising biomarker highlighting its potential as a target aimed at restoring MBNL1 function and correcting downstream splicing abnormalities. The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.